Table 2.
Relative frequencies of reliable improvement of the Patient Health Questionnaire-9 (PHQ-9), pre-post change on the PHQ-9 (effect sizes) and adherence by patient group of early change.
| Sample | Outcome | Adherence | ||||
| n | Reliable improvement on PHQ-9a n (%) |
Pre-post ESb on PHQ-9 (d) (95% CI) |
Usage time (in hours) mean (SDc) |
Number of modules of the Web intervention mean (SD) |
Number of assessmentsd mean (SD) |
|
| All patients | 409 | 221 (54) | 1.12 (0.94-1.30) | 7.89 (4.81) | 9.10 (4.38) | 2.52 (1.25) |
| Class 1e | 158 | 99 (62) | 1.63 (1.39-1.86) | 8.36 (4.08) | 9.84 (3.90) | 2.80 (1.16) |
| Class 2f | 185 | 104 (56) | 1.25 (1.04-1.47) | 7.32 (4.69) | 8.64 (4.52) | 2.37 (1.25) |
| Class 3g | 66 | 18 (27) | −0.47 (−1.05 to 0.12) | 8.33 (6.39) | 8.65 (4.85) | 2.27 (1.36) |
| P value | <.001h | <.001i | .10i | .03i | <.001i | |
aPHQ-9: Patient Health Questionnaire-9.
bES: effect size.
cSD: standard deviation.
dNumber of assessments: Number of PHQ-9s after week 4.
eClass 1: Early response after registration.
fClass 2: Early response after screening.
gClass 3: Early deterioration.
hχ2 tests were performed, testing the association between class membership and categorized treatment outcome.
i1-way analysis of variances (ANOVAs) were performed, testing the association between class membership and mean d for pre-post change, usage time, number of modules of the Web intervention, and number of assessments.